2019
Chronic Atypical Depression as an Early Feature of Pituitary Adenoma: A Case Report and Literature Review
Cardoso F, Azizi H, Kilpatrick A, Olayinka O, Khan T, Kahn A, Canale C, Ojimba C, Popoola O, Nuthalapati D, Ahmad M, Iskander M, Chohan A, Parisi S, Umesi U, Kalbouneh H, Bhattacharya A, Kodjo K, Jegede O, Jolayemi A. Chronic Atypical Depression as an Early Feature of Pituitary Adenoma: A Case Report and Literature Review. Case Reports In Psychiatry 2019, 2019: 4892183. PMID: 31428501, PMCID: PMC6679844, DOI: 10.1155/2019/4892183.Peer-Reviewed Original ResearchOn Neuropsychiatric Manifestations of Basal Ganglia Injury: A Report of Three Cases and Literature Review
Azizi H, Kilpatrick A, Olayinka O, Poopola O, Ahmad M, Kahn A, Khan T, Rimawi D, Williams S, Jayaraj S, Leung I, Langdon S, Iskander M, Chohan A, Nuthalapati D, Umesi U, Vyas G, Oyelakin A, Kodjo K, Ojimba C, Jegede O, Nisenoff C, Jolayemi A. On Neuropsychiatric Manifestations of Basal Ganglia Injury: A Report of Three Cases and Literature Review. Case Reports In Neurological Medicine 2019, 2019: 3298791. PMID: 31080680, PMCID: PMC6475530, DOI: 10.1155/2019/3298791.Peer-Reviewed Original ResearchBasal ganglia pathologyNeuropsychiatric manifestationsBasal gangliaBilateral basal ganglia calcificationBasal ganglia injuryTreatment-refractory psychosisBasal ganglia calcificationDiagnosis of schizophreniaRefractory psychosisVisual disturbancesClinical evidenceMotor functionPsychiatric symptomsNeurological etiologyPsychotic symptomsSymptomsAffective disturbancesSubsequent manifestationPsychotic disturbancesPathologyMotor processingPatientsGangliaManifestationsThird case
2018
The Use of Stimulant Augmentation of Second Generation Antipsychotics in the Management of Negative Symptoms of Schizophrenia: A Case Report
Azizi H, Zeng Y, Kallikkadan J, Kahn A, Olayinka O, Popoola O, Khan T, Rimawi D, Malik A, Williams S, Langdon S, Obegolu C, Nuthalapati D, Alzear R, Kalbouneh H, Mahbub A, Ojimba C, Oyelakin A, Kodjo K, Ferdous Saad A, Jegede O, Jolayemi A. The Use of Stimulant Augmentation of Second Generation Antipsychotics in the Management of Negative Symptoms of Schizophrenia: A Case Report. International Journal Of Innovative Research In Medical Science 2018, 3 DOI: 10.23958/ijirms/vol03-i08/08.Peer-Reviewed Original ResearchNegative symptomsMesocortical pathwayStimulant medicationSymptom subscalesTwo-point reductionClasses of medicationsSecond-generation antipsychoticsPositive symptom subscaleThree-week trialNegative symptom subscaleAntipsychotic therapyNegative syndrome scoreGeneration antipsychoticsCase reportSyndrome scoreDopamine activityMedicationsSymptomsSchizophreniaThree-week periodScoresPotential benefitsSubscalesOlfactory Reference Syndrome with Suicidal Attempt Treated with Pimozide and Fluvoxamine
Jegede O, Virk I, Cherukupally K, Germain W, Fouron P, Olupona T, Jolayemi A. Olfactory Reference Syndrome with Suicidal Attempt Treated with Pimozide and Fluvoxamine. Case Reports In Psychiatry 2018, 2018: 7876497. PMID: 29850350, PMCID: PMC5925182, DOI: 10.1155/2018/7876497.Peer-Reviewed Original ResearchOlfactory reference syndromeSuicidal attemptsPast psychiatric historySocial functioningInpatient psychiatric unitThree-year historyAfrican American womenOutpatient clinicEmergency roomPsychiatric historyPsychiatric unitPatientsSuicide attemptsCore symptomatologyDepressed moodSignificant depressed moodMultiple visitsPresent caseAmerican womenPimozideFluvoxamineSyndromeSymptomsVaginaHospitalization